| Literature DB >> 29472740 |
Lucas Marques1, Emerson Franchini2, Gustavo Drago1, Marcelo S Aoki3, Alexandre Moreira2.
Abstract
Block periodization (BP) has been proposed as an alternative approach for application in the context of high-level sports. Despite its growing acceptance, there is no empirical evidence of BP adoption in high-level judo athletes. Therefore, this study aimed to compare the maximal strength, muscle power, judo-specific performances, and hormonal concentration changes of state/national level (NG) and international level (IG) judo athletes subjected to BP. Twenty-one elite judo athletes (international level = 10; 21.7±1.9 years, 167.2±7.6 cm, 67.6±9.4 kg, 15.7±1.9 years of practice; national level = 11; 21.9±3.0 years, 167.5±9.1 cm, 71.8±16.5, 15.9±3.0 years of practice) were subjected to 13-week BP training (5-week accumulation phase [ACP], 5-week transmutation phase [TP], and 3-week realization phase [RP]). The judo-specific performance (SJFT) increased as there was observed a decrease in the SJFT index (final heart rate [HR] (bpm) + HR1 min after the test divided by the number of throws) for both NG (effect size [ES] = 0.83) and IG (ES = 0.53) from ACP to TP (p < 0.05). The row exercise maximal strength decreased (p < 0.05; ES = 1.35) after the ACP but returned to the baseline level after the TP, for the whole group (ES = 1.39). The athletes did seem to cope appropriately with the demands of BP, as besides increases in SJFT performance no significant changes were observed for cortisol and testosterone concentrations. This is the first study to demonstrate that judo athletes from different competitive levels subjected to BP improved SJFT, likely due to an appropriate balance between training loads and recovery. Thus, the BP approach may be a useful alternative periodization strategy for high-level judo athletes.Entities:
Keywords: Athletic performance; Combat sports; Physiology; Salivary cortisol; Salivary testosterone
Year: 2017 PMID: 29472740 PMCID: PMC5819464 DOI: 10.5114/biolsport.2017.69825
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 2.806
FIG. 1Schematic representation of experimental study design. The 13-week block periodization training.
FIG. 2Percentage of the type of performed exercise in each block periodization phase.
Note: ACP = accumulation phase; TP = transmutation phase; RP = realization phase).
FIG. 3Training load of physical training sessions performed during accumulation (ACP), transmutation (TP) and realization phase (RP) (mean ± SD).
Cortisol and testosterone concentrations at the three time-points collection (mean ± SD).
| Cortisol (ηmol·L-1) | Testosterone (ρmol·L-1) | |||
|---|---|---|---|---|
| IG | NG | IG | NG | |
| T1 | 5.7 ± 1.8 | 6.4 ± 3.9 | 414.8 ± 215.0 | 381.5 ± 98.6 |
| T2 | 6.4 ± 1.6 | 8.6 ± 2.3 | 358.8 ± 174.3 | 389.9 ± 108.8 |
| T3 | 7.4 ± 3.2 | 5.5 ± 1.7 | 519.2 ± 221.6 | 360.3 ± 90.8 |
T1 = beginning of the accumulation phase; T2 = after accumulation phase;
T3 = after the transmutation phase; IG = International group; NG = national group.
Performance tests across the block periodization training.
| NG | IG | |||||
|---|---|---|---|---|---|---|
| T1 | T2 | T3 | T1 | T2 | T3 | |
| SJ (cm) | 20.81±3.41 | 22.28±2.99 | 22.15±3.15 | 24.36±4.64 | 25.30±2.73 | 24.66±3.15 |
| CMJ (cm) | 23.10±5.23 | 23.86±7.80 | 24.10±7.08 | 28.36±3.99 | 29.08±4.96 | 29.76±4.12 |
| Rowing 1RM (kg/kg) | 1.05±0.24 | 0.76±0.22 | 1.08±0.26 | 1.09±0.17 | 0.77±0.15 | 1.13±0.17 |
T1 = at the beginning of the accumulation phase; T2 = after accumulation phase; T3 = after the transmutation phase; SJ = squat jump; CMJ = countermovement jump; 1RM = one-repetition maximum
significant difference (p < 0.001) between T2-T1, and T2-T3 for both groups. NG = national group; IG = International group.
The number of throws for each set and HR for each time-collection point (mean ± SD).
| SET | Number of throws | HR | HR 1min | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | ||||||||
| IG | NG | IG | NG | IG | NG | IG | NG | IG | NG | |
| T1 | 6.5 ± 0.5 | 5.7 ± 0.4 | 11.5 ± 1.1 | 10.8 ± 0.9 | 10.8 ± 0.8 | 10.0 ± 0.8 | 180 ± 6.4 | 183 ± 5 | 165 ± 8 | 170 ± 6 |
| T2 | 6.5 ± 0.5 | 5.5 ± 0.5 | 11.8 ± 1.0 | 10.8 ± 0.9 | 11.0 ± 0.7 | 10.3 ±0.7 | 181 ± 5.4 | 185 ± 5 | 164 ±7 | 166 ± 7 |
| T3 | 6.5 ± 0.5 | 6.5 ± 0.5 | 12.0 ± 0.7 | 10.8 ± 0.9 | 11.0 ± 0.7 | 10.5 ± 0.5 | 183 ± 5.4 | 185 ± 5 | 162 ± 5 | 165 ± 6 |
T1 = beginning of the accumulation phase; T2 = after accumulation phase; T3 = after the transmutation phase; IG = International group; NG = national group; HR = heart rate immediately after the test; HR 1min = heart rate 1 minute after the test.
FIG. 4SJFT index at each assessed time point for the whole group (A) and the SJFT index at each assessed time point separated by groups (B).
Note: mean ± SD; a = different from T2 (p = 0.016); b = different from T3 (p < 0.001). T1 = beginning of the accumulation phase; T2 = after accumulation phase, and T3 = after the transmutation phase. ES= effect size.